HUMBL Inc (HMBL): Here, let me help you. At 11:54AM DYODD...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

HUMBL Inc (HMBL)

Reply Private New

Keep Last Read

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Followers	88
Posts	8284
Boards Moderated	0
Alias Born	02/02/2015

Re: ListenToTheTrees post# 145242

Wednesday, 05/28/2025 8:40:20 PM

Wednesday, May 28, 2025 8:40:20 PM

Here, let me help you. At 11:54AM DYODD posted this >>

"10-K is imminent!"

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176246553 >>

Huggy replied >>

"The 10-K has already been filed"

https://investorshub.advfn.com/boards/replies.aspx?msg=176246553 >>

The mocking began >>

"In the meantime keep waiting on that 10-K."

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176248820 >>

Do you understand now? Please read the WHOLE thread. You'll be smarter for it.

Keep Last Read

Replies (4) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent HMBL News

Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 07/09/2025 03:00:05 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/05/2025 09:30:06 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/09/2025 09:31:33 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 04/30/2025 08:47:31 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 04/18/2025 08:05:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2025 08:34:05 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2025 03:30:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2025 08:10:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2025 10:13:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2025 10:27:27 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/26/2024 09:05:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 07:25:49 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/20/2024 02:43:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2024 09:05:16 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/11/2024 10:21:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2024 03:42:45 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2024 09:00:38 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2024 11:14:27 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 04:10:18 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/11/2024 08:35:17 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/30/2024 08:40:44 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:53:54 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 08:16:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:05:13 PM

More HMBL News

InvestorsHub NewsWire

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM

VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM

Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM

Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow